ES2525215T3 - Derivado morfinano sustituido con 7-carbamoilo-6,7-insaturado - Google Patents

Derivado morfinano sustituido con 7-carbamoilo-6,7-insaturado Download PDF

Info

Publication number
ES2525215T3
ES2525215T3 ES06746833.0T ES06746833T ES2525215T3 ES 2525215 T3 ES2525215 T3 ES 2525215T3 ES 06746833 T ES06746833 T ES 06746833T ES 2525215 T3 ES2525215 T3 ES 2525215T3
Authority
ES
Spain
Prior art keywords
chiral
optionally substituted
brs
nmr
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06746833.0T
Other languages
English (en)
Spanish (es)
Inventor
Masanao Inagaki
Shin-Ichiro Hara
Nobuhiro Haga
Yoshinori Tamura
Yoshihisa Goto
Tsuyoshi Hasegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2525215T3 publication Critical patent/ES2525215T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES06746833.0T 2005-05-25 2006-05-25 Derivado morfinano sustituido con 7-carbamoilo-6,7-insaturado Active ES2525215T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2005151864 2005-05-25
JP2005151864 2005-05-25
JP2006065762 2006-03-10
JP2006065762 2006-03-10
WOPCT/JP2006/310231 2006-05-23
PCT/JP2006/310231 WO2006126529A1 (ja) 2005-05-25 2006-05-23 ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
PCT/JP2006/310454 WO2006126637A1 (ja) 2005-05-25 2006-05-25 ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体

Publications (1)

Publication Number Publication Date
ES2525215T3 true ES2525215T3 (es) 2014-12-19

Family

ID=37451954

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06746833.0T Active ES2525215T3 (es) 2005-05-25 2006-05-25 Derivado morfinano sustituido con 7-carbamoilo-6,7-insaturado

Country Status (20)

Country Link
US (4) US8084460B2 (member.php)
EP (1) EP1889848B8 (member.php)
JP (1) JP4323547B2 (member.php)
KR (1) KR100912782B1 (member.php)
CN (1) CN101228172B (member.php)
AU (1) AU2006250390B2 (member.php)
BE (1) BE2019C533I2 (member.php)
BR (1) BRPI0610343B8 (member.php)
CA (1) CA2609733C (member.php)
DK (1) DK1889848T3 (member.php)
ES (1) ES2525215T3 (member.php)
FR (1) FR19C1042I2 (member.php)
HU (1) HUS1900034I1 (member.php)
MX (1) MX2007014588A (member.php)
NL (1) NL300996I2 (member.php)
PL (1) PL1889848T3 (member.php)
PT (1) PT1889848E (member.php)
RU (1) RU2403255C2 (member.php)
TW (1) TWI311056B (member.php)
WO (2) WO2006126529A1 (member.php)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
CA2749273C (en) * 2008-01-09 2018-09-04 Charleston Laboratories, Inc. Pharmaceutical oral dosage form comprising a triptan and an antiemetic
JP5252391B2 (ja) * 2008-02-21 2013-07-31 学校法人北里研究所 オキサビシクロ［２．２．２］オクタンを有するモルヒナン誘導体およびその医薬用途
US20110237614A1 (en) * 2008-09-16 2011-09-29 Nektar Therapeutics Pegylated Opioids with Low Potential for Abuse
AU2010295464B2 (en) * 2009-09-18 2015-11-26 Merck Sharp & Dohme Corp. Use of opioid receptor antagonist for gastrointestinal tract disorders
EP2569320A4 (en) * 2010-05-13 2014-03-19 Green Cross Corp POLYCYCLIC DERIVATIVES ON (+) - 3-HYDROXYMORPHINAN BASE AS NEUROPROTEKTIVA
SI2639234T1 (sl) * 2010-11-12 2019-10-30 Shionogi & Co Derivat kristaliničnega 6,7-nenasičenega-7-karbamoil morfinana in postopek njegove izdelave
CA2873961C (en) 2012-05-14 2017-09-26 Shionogi & Co., Ltd. Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
WO2018124062A1 (ja) 2016-12-26 2018-07-05 塩野義製薬株式会社 含量均一性を改善した製剤の製造方法
TWI856956B (zh) 2018-04-12 2024-10-01 美商莫菲克醫療股份有限公司 人類整合素α４β７拮抗劑
KR102201609B1 (ko) 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN115087444B (zh) 2019-10-16 2024-09-17 莫菲克医疗股份有限公司 抑制人整联蛋白α4β7
JP7582961B2 (ja) 2019-11-20 2024-11-13 塩野義製薬株式会社 ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有固形製剤
CN111905111B (zh) * 2020-09-16 2023-03-31 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法
IT202300009864A1 (it) * 2023-05-16 2024-11-16 Procos Spa Processo per la preparazione di naldemedina

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272541A (en) * 1978-06-02 1981-06-09 Miles Laboratories, Inc. 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them
US4275205A (en) * 1980-05-05 1981-06-23 Miles Laboratories, Inc. 7,7-Ditosyloxymethyl-4,5α-epoxy-morphinan-6-ols
US4347361A (en) * 1980-12-10 1982-08-31 Sisa, Incorporated 4,5α-Epoxy-3-hydroxy or methoxy-7-(1-hydroxy-alkyl or 1-oxoalkyl)morphinan-6-one compounds
US4370333A (en) * 1981-06-29 1983-01-25 Sisa, Incorporated 17-Cyclopropylmethyl-3-hydroxy-14-methoxy 7α-methyl-morphinan-6-one and therapeutic method of treating pain with it
US4443605A (en) * 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
US4440932A (en) * 1982-09-09 1984-04-03 Miles Laboratories, Inc. 7β-Arylalkyl-7α-methyl-6-oxo or 6α-hydroxy-3-methoxy or 3-hydroxy-4,5α-epoxy-17-methyl or 17-cycloalkyl-methylmorphinans
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
EP0663401B1 (en) 1993-07-23 2000-06-07 Toray Industries, Inc. Morphinan derivative and medicinal use
US5464841A (en) 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
EP0880526B1 (en) 1996-01-10 2002-12-18 GlaxoSmithKline S.p.A. Heterocycle-condensed morphinoid derivatives (ii)
WO2001002375A1 (en) 1999-07-01 2001-01-11 Chemrx Advanced Technologies, Inc. Process for synthesizing oxadiazoles
US6451806B2 (en) * 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
ES2278647T3 (es) * 1999-11-29 2007-08-16 Adolor Corporation Nuevos procedimientos y composiciones que comprenden opioides y antagonistas de opioides.
AU5956001A (en) 2000-05-05 2001-11-20 Pain Therapeutics Inc Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
US20040024004A1 (en) 2001-05-04 2004-02-05 Sherman Barry M. Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
WO2001085257A2 (en) 2000-05-05 2001-11-15 Pain Therapeutics, Inc. Opioid antagonist compositions and dosage forms
WO2002036573A2 (en) 2000-10-31 2002-05-10 Rensselaer Polytechnic Institute 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
CA2427931A1 (en) * 2000-11-22 2002-05-30 Toray Industries, Inc. Indole derivatives and medical applications thereof
RU2297419C2 (ru) * 2001-08-23 2007-04-20 Акцо Нобель Н.В. Производное 14-гидроксинорморфинона, производное морфинона, производное морфина, способы получения производного 14-гидроксинорморфинона, производное морфинона, нороксиморфона
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
CN1288158C (zh) 2002-07-11 2006-12-06 东丽株式会社 用于预防恶心和呕吐的治疗剂或预防剂
CA2498046A1 (en) 2002-09-18 2004-04-01 The Curators Of The University Of Missouri Opiate analogs selective for the delta-opioid receptor
US20040157784A1 (en) * 2003-02-10 2004-08-12 Jame Fine Chemicals, Inc. Opiod tannate compositions
WO2005105093A2 (en) 2003-08-26 2005-11-10 Duke University METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION
DK1758452T3 (en) 2004-05-28 2017-05-01 Human Biomolecular Res Inst METABOLIC STABLE ANALGETICS AND Painkillers
US20060063792A1 (en) 2004-09-17 2006-03-23 Adolor Corporation Substituted morphinans and methods of their use
US7142420B2 (en) 2004-09-20 2006-11-28 Qualcomm, Incorporated Devices and methods for controlling relative movement between layers of an electronic device
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
SI2639234T1 (sl) 2010-11-12 2019-10-30 Shionogi & Co Derivat kristaliničnega 6,7-nenasičenega-7-karbamoil morfinana in postopek njegove izdelave

Also Published As

Publication number Publication date
US20120135978A1 (en) 2012-05-31
NL300996I1 (nl) 2019-07-03
KR20080014791A (ko) 2008-02-14
WO2006126637A1 (ja) 2006-11-30
NL300996I2 (nl) 2019-07-30
RU2007148412A (ru) 2009-06-27
EP1889848A1 (en) 2008-02-20
JP4323547B2 (ja) 2009-09-02
US20090203723A1 (en) 2009-08-13
BE2019C533I2 (member.php) 2025-12-10
TW200726470A (en) 2007-07-16
EP1889848B1 (en) 2014-10-15
TWI311056B (en) 2009-06-21
BRPI0610343A2 (pt) 2010-06-15
CA2609733C (en) 2011-07-19
KR100912782B1 (ko) 2009-08-18
RU2403255C2 (ru) 2010-11-10
FR19C1042I1 (member.php) 2019-08-09
MX2007014588A (es) 2008-01-24
WO2006126529A1 (ja) 2006-11-30
USRE46365E1 (en) 2017-04-11
USRE46375E1 (en) 2017-04-25
US8536192B2 (en) 2013-09-17
JPWO2006126637A1 (ja) 2008-12-25
PL1889848T3 (pl) 2015-04-30
AU2006250390A1 (en) 2006-11-30
CA2609733A1 (en) 2006-11-30
CN101228172B (zh) 2013-04-03
DK1889848T3 (en) 2014-12-01
AU2006250390B2 (en) 2010-07-08
PT1889848E (pt) 2014-12-09
BRPI0610343B8 (pt) 2021-05-25
EP1889848A4 (en) 2011-08-10
FR19C1042I2 (fr) 2020-06-19
US8084460B2 (en) 2011-12-27
EP1889848B8 (en) 2014-12-17
CN101228172A (zh) 2008-07-23
HUS1900034I1 (hu) 2019-07-29
BRPI0610343B1 (pt) 2020-03-10

Similar Documents

Publication Publication Date Title
ES2525215T3 (es) Derivado morfinano sustituido con 7-carbamoilo-6,7-insaturado
EP3820574B1 (en) 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases
EP3672949B9 (en) 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
EP3885342B1 (en) Bicyclic inhibitors of pad4
EP2520567A2 (en) Nitrogen-containing heterocycle derivatives substituted with cyclic group
US20090318408A1 (en) Halo-substituted pyrimidodiazepines
US9630922B2 (en) 3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors
RU2475488C2 (ru) Дигидродиазепины, которые можно использовать в качестве ингибиторов протеинкиназ
US20140235626A1 (en) Pyridine derivatives and a pharmaceutical composition for inhibiting bace1 containing them
CN101420955B (zh) 可用作蛋白激酶抑制剂的二氢二氮杂*
RU2008122070A (ru) Аминопиридины, используемые в качестве ингибиторов киназ
CN101678022A (zh) 可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
EP2277881A1 (en) Heterocyclic compound having inhibitory activity on p13k
US20250163049A1 (en) Fused bicyclic heterocyclyl compounds as usp1 inhibitors
US6765096B1 (en) Tricyclic compound having acyloxymethoxycarbonyl side chain
US20180360803A1 (en) Pharmaceutical composition for treatment or prevention of nash
ES2561298T3 (es) Compuestos de aminometilquinolona
US6103732A (en) Carboxylic acid derivatives, their production and use
TW202502345A (zh) Wrn抑制劑
US12177971B2 (en) Wiring board
JP4737495B2 (ja) エリスロマイシン誘導体
US6225478B1 (en) Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
EP4470533A1 (en) Novel b0at1 inhibitor
ES2447891T3 (es) Procedimiento para la preparación de beta-cetonitrilos
US20040034076A1 (en) Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists